BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25924439)

  • 21. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of tumor stage on prognosis in children with adrenocortical carcinoma.
    Tucci S; Martins AC; Suaid HJ; Cologna AJ; Reis RB
    J Urol; 2005 Dec; 174(6):2338-42, discussion 2342. PubMed ID: 16280838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.
    Heinze B; Herrmann LJ; Fassnacht M; Ronchi CL; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
    Eur J Endocrinol; 2014 May; 170(5):707-17. PubMed ID: 24566897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
    Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes after resection of cortisol-secreting adrenocortical carcinoma.
    Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Glenn JA; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Am J Surg; 2016 Jun; 211(6):1106-13. PubMed ID: 26810939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
    Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.
    Amini N; Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):126-33. PubMed ID: 26282907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
    Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
    Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
    Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
    BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
    Tran TB; Maithel SK; Pawlik TM; Wang TS; Hatzaras I; Phay JE; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Poultsides GA
    J Am Coll Surg; 2016 Dec; 223(6):794-803. PubMed ID: 27618748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.
    Fassnacht M; Johanssen S; Quinkler M; Bucsky P; Willenberg HS; Beuschlein F; Terzolo M; Mueller HH; Hahner S; Allolio B; ;
    Cancer; 2009 Jan; 115(2):243-50. PubMed ID: 19025987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathological staging criteria for carcinoma in the remnant stomach: an exploratory study].
    Gao Z; Zhao X; Jiang K; Wang B; Li Y; Ye Y; Wang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):514-521. PubMed ID: 29774932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study.
    Nilubol N; Patel D; Kebebew E
    World J Surg; 2016 Mar; 40(3):697-705. PubMed ID: 26510563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenocortical carcinoma: Retrospective analysis of the last 22 years.
    Guelho D; Paiva I; Vieira A; Carrilho F
    Endocrinol Nutr; 2016 May; 63(5):212-9. PubMed ID: 26969077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993.
    Kerkhofs TM; Verhoeven RH; Van der Zwan JM; Dieleman J; Kerstens MN; Links TP; Van de Poll-Franse LV; Haak HR
    Eur J Cancer; 2013 Jul; 49(11):2579-86. PubMed ID: 23561851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
    Bao L; Ding Y; Cai Q; Ning Y; Hu W; Xue X; Sun H; Hua K; Zhou X; Yi X
    Int J Gynecol Cancer; 2016 Mar; 26(3):424-30. PubMed ID: 26825825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.